18F-FDG PET最大强度投影与人工智能:轻松测量DLBCL患者预后生物标志物的双赢组合
本研究回顾性分析REMARC和LNH073B两项试验中的382例弥漫性大B细胞淋巴瘤(DLBCL)患者,训练人工智能算法仅从全身18F-FDG PET的2幅最大强度投影(MIP)图像自动估算替代性总代谢肿瘤体积(sTMTV)和替代性肿瘤播散(sDmax),并与专家勾画的全景TMTV和Dmax比较分层能力。结果显示sTMTV与TMTV、sDmax与Dmax相关性高,基于MIP特征的风险比与原始特征相似。
要点
- AI可从2幅PET MIP图像自动估算sTMTV和sDmax。
- sTMTV与TMTV高度相关(REMARC r=0.878,LNH073B r=0.752)。
- 基于MIP的sTMTV和sDmax对无进展生存的分层风险比与原始特征相似。
核心结论
- 仅从2幅PET MIP图像计算的替代性TMTV和Dmax是DLBCL患者的预后生物标志物,并可用AI算法自动估算。
研究设计与样本
- 回顾性分析REMARC(NCT01122472)和LNH073B(NCT00498043)两项试验中的DLBCL患者队列,共382例(平均年龄62.1岁±13.4岁;207例男性),由专家从基线全身18F-FDG PET/CT图像勾画淋巴瘤病灶并测量TMTV和Dmax,计算冠状面和矢状面MIP图像及对应的二维参考病灶掩膜,在REMARC的MIP数据上训练AI算法分割淋巴瘤区域,并用于两个数据集估算sTMTV和sDmax。
主要发现
- sTMTV与TMTV在REMARC和LNH073B数据集中高度相关(Spearman r分别为0.878和0.752),sDmax与Dmax亦高度相关(r分别为0.709和0.714)。
- 基于体积和基于MIP的AI衍生特征对无进展生存的风险比相似,例如TMTV:11.24(95%CI:2.10-46.20),sTMTV:11.81(95%CI:3.29-31.77),Dmax:9.0(95%CI:2.53-23.63),sDmax:12.49(95%CI:3.42-34.50)。
临床怎么用
- 原文结论认为,仅从2幅PET MIP图像计算的替代性TMTV和Dmax是DLBCL患者的预后生物标志物,并可用AI算法自动估算。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Total metabolic tumor volume (TMTV) and tumor dissemination (Dmax) calculated from baseline 18F-FDG PET/CT images are prognostic biomarkers in diffuse large B-cell lymphoma (DLBCL) patients. Yet, their automated calculation remains challenging. The purpose of this study was to investigate whether TMTV and Dmax features could be replaced by surrogate features automatically calculated using an artificial intelligence (AI) algorithm from only 2 maximum-intensity projections (MIPs) of the whole-body 18F-FDG PET images. Methods: Two cohorts of DLBCL patients from the REMARC (NCT01122472) and LNH073B (NCT00498043) trials were retrospectively analyzed. Experts delineated lymphoma lesions from the baseline whole-body 18F-FDG PET/CT images, from which TMTV and Dmax were measured. Coronal and sagittal MIP images and associated 2-dimensional reference lesion masks were calculated. An AI algorithm was trained on the REMARC MIP data to segment lymphoma regions. The AI algorithm was then used to estimate surrogate TMTV (sTMTV) and surrogate Dmax (sDmax) on both datasets. The ability of the original and surrogate TMTV and Dmax to stratify patients was compared. Results: Three hundred eighty-two patients (mean age ± SD, 62.1 y ± 13.4 y; 207 men) were evaluated. sTMTV was highly correlated with TMTV for REMARC and LNH073B datasets (Spearman r = 0.878 and 0.752, respectively), and so were sDmax and Dmax (r = 0.709 and 0.714, respectively). The hazard ratios for progression free survival of volume and MIP-based features derived using AI were similar, for example, TMTV: 11.24 (95% CI: 2.10-46.20), sTMTV: 11.81 (95% CI: 3.29-31.77), and Dmax: 9.0 (95% CI: 2.53-23.63), sDmax: 12.49 (95% CI: 3.42-34.50). Conclusion: Surrogate TMTV and Dmax calculated from only 2 PET MIP images are prognostic biomarkers in DLBCL patients and can be automatically estimated using an AI algorithm.
引用
- Girum KB, Rebaud L, Cottereau AS, et al. 18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients. J Nucl Med. 2022. PMID: 35710733. doi:10.2967/jnumed.121.263501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。